Cytiva Fibro PrismA antibody purification technology

Monday, 12 October, 2020 | Supplied by: Cytiva



Cytiva’s Fibro PrismA antibody purification technology has been designed to support the industry’s drive for increased speed and flexibility, in order to advance the development of novel therapeutics. The first product based on the company’s protein A fibre chromatography technology, it is being used to accelerate research for customers and collaborators.

Fibro chromatography technology enables rapid cycling antibody purification. In research and process development, this means Fibro PrismA can support up to 20 times increased throughput compared with traditional resins, the company claims. In clinical and commercial manufacturing, the technology will enable efficient single-use operations, by using the full unit lifetime in a single batch.

Fibro PrismA enables ultrafast purification in research and process development, allowing researchers to accelerate the drug discovery process. Clinical-scale products are set to follow.

Online: www.cytivalifesciences.com/en/au
Phone: 1800 150 522
Related Products

TOPTICA FemtoFiber ultra 920 laser system

The FemtoFiber ultra series of compact laser systems, by TOPTICA, provide femtosecond pulses with...

Scientifica SliceScope Pro 3000 electrophysiology system

The SliceScope Pro 3000 electrophysiology system from Scientifica is a fixed microscope imaging...

Thermo Scientific Tox Explorer Collection

By using the Thermo Scientific Tox Explorer Collection, clinical research, forensic and...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd